<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01387802</url>
  </required_header>
  <id_info>
    <org_study_id>P12-672</org_study_id>
    <nct_id>NCT01387802</nct_id>
  </id_info>
  <brief_title>Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis</brief_title>
  <acronym>Complete-AS</acronym>
  <official_title>Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie (prior sponsor, Abbott)</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>JSS Medical Research Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cato Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study will assess the real - life effectiveness of adalimumab in the management
      of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of
      extra-articular manifestations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 29, 2011</start_date>
  <completion_date type="Actual">December 16, 2019</completion_date>
  <primary_completion_date type="Actual">December 16, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Uveitis</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Psoriasis</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Inflammatory Bowel Disease</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Enthesitis of the Heel: Achilles Tendon and Plantar Fascia</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BASFI (Bath AS Functional Assay)</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>This is a 100 VAS with 0 indicating lowest functional limitations and 10 highest functional limitations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PASQ (Psoriasis and Arthritis Screening Questionnaire)</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>This is an 11 item tool that ascertains self reported presence of joint pain and swelling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BASDAI (Bath AS Disease Activity Index)</measure>
    <time_frame>Every 3 months up to 6 months, then every 6 months up to 24 months</time_frame>
    <description>This is a 100 VAS with 0 indicating lowest disease activity and 10 highest disease activity</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">722</enrollment>
  <condition>Ankylosing Spondylitis</condition>
  <arm_group>
    <arm_group_label>Non-Biologic arm</arm_group_label>
    <description>Patients that have not responded to the current treatment with an NSAID (Nonsteroidal Anti-Inflammatory Drug) and/or non - biologic DMARD (Disease-Modifying Anti Rheumatic Drug) for peripheral joint involvement and switch to or addition of another NSAID /DMARDS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biologic arm</arm_group_label>
    <description>Patients that have not responded to the current treatment with non biologic DMARDS (Disease-Modifying Anti Rheumatic Drug) /NSAID (Nonsteroidal Anti-Inflammatory Drug) and switch to or addition of adalimumab</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Offices of community rheumatologists
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult &gt;= 18 years old

          -  Has provided written informed consent allowing the use of their data for the study and
             providing permission for contact by the study personnel

          -  Active Ankylosing Spondylitis as per the judgment of the treating physician

          -  Inadequate response or non tolerant to current NSAID (Nonsteroidal Anti-Inflammatory
             Drug) or DMARD (Disease-Modifying Anti Rheumatic Drug) based treatment for AS

        Exclusion Criteria:

          -  Currently participating in another prospective study including controlled clinical
             trials and observational studies

          -  Patient cannot or will not sign informed consent

          -  Stable disease with adequate tolerance and response to current treatment and no change
             in treatment is indicated

          -  Previous treatment with anti-TNF (Tumor Necrosis Factor) or other biologic agent

          -  Presence of other condition that, in the opinion of the treating physician, prohibits
             the patient from participating in the study or obscures the assessment of the
             treatment of AS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AbbVie Inc.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rheumatology Clinic /ID# 54768</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2P 0V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associate Clinic /ID# 64274</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2P 3C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pont, Cranbrook, BC, CA /ID# 55242</name>
      <address>
        <city>Cranbrook</city>
        <state>British Columbia</state>
        <zip>V1C 2R7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Barbara T. Blumenauer Inc. /ID# 55226</name>
      <address>
        <city>Kamloops</city>
        <state>British Columbia</state>
        <zip>V2C 0B8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hudson, Kamloops, Canada /ID# 54577</name>
      <address>
        <city>Kamloops</city>
        <state>British Columbia</state>
        <zip>V2C 6G6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Maqbool R. Sheriff Inc. /ID# 55247</name>
      <address>
        <city>Nanaimo</city>
        <state>British Columbia</state>
        <zip>V9S 4S1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stewart, Penticton, CA /ID# 67096</name>
      <address>
        <city>Penticton</city>
        <state>British Columbia</state>
        <zip>V2A 3G7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Michael Buchanan, Inc. /ID# 55227</name>
      <address>
        <city>Prince George</city>
        <state>British Columbia</state>
        <zip>V2L 5R6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. J. Antonio Avina-Zubieta /ID# 68263</name>
      <address>
        <city>Richmond</city>
        <state>British Columbia</state>
        <zip>V6X 2C7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Alfonso Verdejo Inc. /ID# 54572</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 2E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Milton F. Baker Inc. /ID# 55197</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8P 5P6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manitoba Clinic /ID# 54580</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A IM3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bulleid Henderson Prof. Corp. /ID# 55256</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <zip>E3B 6H5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ecker, Fredericton, CA /ID# 54748</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <zip>E3B 6H5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nexus Clinical Research /ID# 54757</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 5E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Clare's Mercy Hospital /ID# 54767</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1C 5B8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qe Ii Hsc /Id# 55261</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Juris Lazovskis Inc. /ID# 61562</name>
      <address>
        <city>Sydney</city>
        <state>Nova Scotia</state>
        <zip>B1S 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pavlova, Hamilton, CA /ID# 65011</name>
      <address>
        <city>Ancaster</city>
        <state>Ontario</state>
        <zip>L9G 3K9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waterside Clinique /ID# 72174</name>
      <address>
        <city>Barrie</city>
        <state>Ontario</state>
        <zip>L4M 6L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joshi, Brampton, Canada /ID# 54758</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6T 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brockville Medical Center /ID# 65502</name>
      <address>
        <city>Brockville</city>
        <state>Ontario</state>
        <zip>K6V 5J9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Sanjay Dixit Medicine Professional Corporation /ID# 67347</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7L 0B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aviva Clinical Trial Group /ID# 54764</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7R 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Chrisotomor Kouroukis &amp; Dr /ID# 137831</name>
      <address>
        <city>Dundas</city>
        <state>Ontario</state>
        <zip>L9H 1B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlton Medical Centre /ID# 133072</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlton Medical Centre /ID# 55417</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. William G. Bensen Centre /ID# 54762</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Mountain Medical Center /ID# 128877</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L9C 5N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KW Musculoskeletal Research /ID# 70093</name>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2M 5N6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brandusa Florica Med Prof Corp /ID# 81877</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5A 3V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montgomery, Mississauga, CA /ID# 54581</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5A 3V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Credit Valley Rheumatology /ID# 54750</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imtiaz MS Khan Medicine Prof /ID# 55401</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 4N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morassut, Nepean, Canada /ID# 55410</name>
      <address>
        <city>Nepean</city>
        <state>Ontario</state>
        <zip>K2G 6E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Arthritis Program Res Grp /ID# 54755</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 3R7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajwinder S. Dhillon Medicine /ID# 138671</name>
      <address>
        <city>Niagara Falls</city>
        <state>Ontario</state>
        <zip>L2E 6A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kapur, Ottawa, Canada /ID# 55397</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K2A 3Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Davis, Ottawa, CA /ID# 55296</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K2P 1V3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Setty, Owen Sound, CA /ID# 54583</name>
      <address>
        <city>Owen Sound</city>
        <state>Ontario</state>
        <zip>N4K 1S4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niagara Peninsula Arthritis Ct /ID# 67282</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <zip>L2N 7E4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pedvis Med Prof Corp /ID# 55411</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4S 2C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton, Toronto, CA /ID# 54575</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4X 1W4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jonathan Stein Med Prof Corp /ID# 55451</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6S 4W4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karasik, Toronto, CA /ID# 54751</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9C 5N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Samuel K Silverberg /ID# 55449</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9V 4B8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ctr de Med Sportive de Laval /ID# 54576</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7T 2Z8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Rhum. de Montreal /ID# 54761</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital /ID# 63655</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PSS Medical Inc. /ID# 54754</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1Y3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Couture, Outremont, CA /ID# 54574</name>
      <address>
        <city>Outremont</city>
        <state>Quebec</state>
        <zip>H2V 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ctr. de Rheum de l'est du QC /ID# 54765</name>
      <address>
        <city>Rimouski</city>
        <state>Quebec</state>
        <zip>G5L 8W1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Medicale Langelier /ID# 55460</name>
      <address>
        <city>Saint-leonard</city>
        <state>Quebec</state>
        <zip>H1S 3A9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe de Recherche en Maladies Osseuses /ID# 45623</name>
      <address>
        <city>Sainte-foy</city>
        <state>Quebec</state>
        <zip>G1V 3M7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ctr. de Recherche Musculo-Sque /ID# 55469</name>
      <address>
        <city>Trois-rivi√®res</city>
        <state>Quebec</state>
        <zip>G8Z 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheum Disease Ctr of Montreal /ID# 143963</name>
      <address>
        <city>Westmount</city>
        <state>Quebec</state>
        <zip>H3Z 2Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://rxabbvie.com</url>
    <description>United States Prescribing Information is provided</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 1, 2011</study_first_submitted>
  <study_first_submitted_qc>July 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2011</study_first_posted>
  <last_update_submitted>December 30, 2019</last_update_submitted>
  <last_update_submitted_qc>December 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Assessing Effectiveness in Ankylosing Spondylitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

